Paper10097072
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu H and 20 others. Proc Natl Acad Sci U S A, 1999. Cited by 1,281 papers, by iCite.
Cite this record
ConductScience Library. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Papers, record 10097072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10097072
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
- PubMed
Topics30
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Gene Expression Regulation, Developmental | Major topic |
| Glycoproteins | Major topic |
| Membrane Glycoproteins | Major topic |
| Mitogen-Activated Protein Kinases | Major topic |
| Osteoclasts | Major topic |
| Receptors, Cytoplasmic and Nuclear | Major topic |
| Receptors, Tumor Necrosis Factor | Major topic |
| Animals | |
| Bone Development | |
| Calcium-Calmodulin-Dependent Protein Kinases | |
| Cell Differentiation | |
| Cell Line | |
| Cloning, Molecular | |
| Humans | |
| Immunoglobulin G | |
| JNK Mitogen-Activated Protein Kinases | |
| Male | |
| Mice | |
| Mice, Inbred Strains | |
| Mice, Transgenic | |
| Osteogenesis | |
| Osteoprotegerin | |
| RANK Ligand | |
| Receptor Activator of Nuclear Factor-kappa B | |
| Recombinant Fusion Proteins | |
| Recombinant Proteins | |
| Signal Transduction | |
| Transcription, Genetic | |
| Transfection |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9685412 | Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9685412 | PubMed |
| 2 | 9730902 | TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. | J Exp Med | 1998 | https://conductscience.org/library/papers/9730902 | PubMed |
| 3 | 9568710 | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. | Cell | 1998 | https://conductscience.org/library/papers/9568710 | PubMed |
| 4 | 9492069 | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. | Endocrinology | 1998 | https://conductscience.org/library/papers/9492069 | PubMed |
| 5 | 9153189 | ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9153189 | PubMed |
| 6 | 8854048 | Advances in bone biology: the osteoclast. | Endocr Rev | 1996 | https://conductscience.org/library/papers/8854048 | PubMed |
| 7 | 8934568 | Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. | Immunity | 1996 | https://conductscience.org/library/papers/8934568 | PubMed |
| 8 | 9724059 | Hypocalcemic effect of osteoclastogenesis inhibitory factor/osteoprotegerin in the thyroparathyroidectomized rat. | Endocrinology | 1998 | https://conductscience.org/library/papers/9724059 | PubMed |
| 9 | 9573043 | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | Genes Dev | 1998 | https://conductscience.org/library/papers/9573043 | PubMed |
| 10 | 9108485 | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | Cell | 1997 | https://conductscience.org/library/papers/9108485 | PubMed |
| 11 | 9784422 | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | Biochem Biophys Res Commun | 1998 | https://conductscience.org/library/papers/9784422 | PubMed |
| 12 | 9950424 | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. | Nature | 1999 | https://conductscience.org/library/papers/9950424 | PubMed |
| 13 | 9647741 | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. | Biochem Biophys Res Commun | 1998 | https://conductscience.org/library/papers/9647741 | PubMed |
| 14 | 9367155 | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. | Nature | 1997 | https://conductscience.org/library/papers/9367155 | PubMed |
| 15 | 9359707 | Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. | Nat Med | 1997 | https://conductscience.org/library/papers/9359707 | PubMed |
| 16 | 2188141 | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. | Nature | 1990 | https://conductscience.org/library/papers/2188141 | PubMed |
| 17 | 9390694 | Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. | Immunity | 1997 | https://conductscience.org/library/papers/9390694 | PubMed |
| 18 | 9520411 | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9520411 | PubMed |
| 19 | 9774460 | The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9774460 | PubMed |
| 20 | 9407039 | Requirement for NF-kappaB in osteoclast and B-cell development. | Genes Dev | 1997 | https://conductscience.org/library/papers/9407039 | PubMed |
Cited by458
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42669154 | Regulating Cells Fate and Function to Facilitate Bone Regeneration via Designing Programmable Bio-Interactive Materials. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42669154 | PubMed |
| 42613538 | Methods for Evaluation of the Differentiation to Osteoblasts and Osteoclasts: Roles of Gangliosides in Bone Metabolisms. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/42613538 | PubMed |
| 42564269 | TNF-α blockade with adalimumab restores bone metabolism in rheumatoid arthritis by regulating cytokines and inflammatory cell infiltration. | Front Immunol | 2026 | https://conductscience.org/library/papers/42564269 | PubMed |
| 42339265 | From 5F hematopoietic progenitors to osteoclasts: a scalable human model of osteoclastogenesis. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42339265 | PubMed |
| 42245910 | From farm to lab: gene-edited sheep transforming bone research. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42245910 | PubMed |
| 41832918 | Bone matrix proteins: regulators of skeletal remodeling and repair. | J Bone Miner Metab | 2026 | https://conductscience.org/library/papers/41832918 | PubMed |
| 41736047 | In vitro characterization of osteoblasts from craniofacial fibrous dysplasia of bone and their impact on bone homeostasis. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/41736047 | PubMed |
| 41671217 | Generation of osteoclast-like cells from human peripheral blood mononuclear cells using NFATc1 modified RNA. | PLoS One | 2026 | https://conductscience.org/library/papers/41671217 | PubMed |
| 41571870 | Bone mineral loss damages renal tubules in mice. | Commun Biol | 2026 | https://conductscience.org/library/papers/41571870 | PubMed |
| 41151042 | Osteoprotective Effects and In Silico Profiling of Parinari curatellifolia Planch. Ex Benth. (Chrysobalanaceae) Extract on Acute Plasmodium berghei-Compromised Rat Bone. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/41151042 | PubMed |
| 41132665 | Macrophages and osteoclasts: similarity and divergence between bone phagocytes. | Front Immunol | 2025 | https://conductscience.org/library/papers/41132665 | PubMed |
| 41096665 | Recent Advances in the Role of Osteocytes in Orthodontic Tooth Movement. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41096665 | PubMed |
| 40962326 | Lefty2 prevents RANKL-induced bone loss by inhibiting osteoclast differentiation. | BMB Rep | 2026 | https://conductscience.org/library/papers/40962326 | PubMed |
| 40813975 | Modeling the effects of radiation on the bone tumor microenvironment: opportunities for exploring combination therapies in microphysiologic systems. | Cell Mol Biol Lett | 2025 | https://conductscience.org/library/papers/40813975 | PubMed |
| 40508197 | Electrospun Poly(L-lactide-co-ε-caprolactone) Nanofibers with Hydroxyapatite Nanoparticles Mimic Cellular Interplay in Bone Regeneration. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508197 | PubMed |
| 40356996 | The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40356996 | PubMed |
| 40338171 | Mechanical control of osteoclast fusion by membrane-cortex attachment and BAR proteins. | J Cell Biol | 2025 | https://conductscience.org/library/papers/40338171 | PubMed |
| 40307216 | Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs. | Bone Res | 2025 | https://conductscience.org/library/papers/40307216 | PubMed |
| 40092569 | Molecular pathological insights into tumorigenesis and progression of giant cell tumor of bone. | J Bone Oncol | 2025 | https://conductscience.org/library/papers/40092569 | PubMed |
| 39821032 | RANK/RANKL Signaling Pathway in Breast Development and Cancer. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/39821032 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TNFRSF11A | 8792 | PubTator's text mining | https://conductscience.org/library/genes/8792 | NCBI Gene |
| TNFRSF11B | 4982 | PubTator's text mining | https://conductscience.org/library/genes/4982 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10097072
GET https://conductscience.org/api/papers/v1/10097072/authors?page=2